ISDA

Entry Detail

PDB ID:

3DBD

Keywords:

TRANSFERASE

Title:

Crystal structure of an activated (Thr->Asp) Polo-like kinase 1 (Plk1) catalytic domain in complex with Compound 094

Biological Source:

Source Organism:

Danio rerio

Host Organism:

Escherichia coli

PDB Version:

Deposition Date:

2008-05-31

Release Date:

2008-10-07

Method Details:

Experimental Method:

X-RAY DIFFRACTION

Resolution:

3.05 Å

R-Value Free:

0.27

R-Value Work:

0.24

R-Value Observed:

0.25

Space Group:

I 2 3

Download Validation Report

Macromolecular Entities

Protein Blast

Polymer Type:polypeptide(L)
Description:Polo-like kinase 1
Mutations:T196D
Chain IDs:A
Chain Length:317
Number of Molecules:1
Biological Source:Danio rerio

UniProt ID:Q4KMI8 Pfam ID:PF00069 EC:2.7.11.21

Ligand Molecules

3FR

Primary Citation

Design and synthesis of 2-amino-pyrazolopyridines as Polo-like kinase 1 inhibitors.

Fucini, R.V, Hanan, E.J, Romanowski, M.J, Elling, R.A, Lew, W, Barr, K.J, Zhu, J, Yoburn, J.C, Liu, Y, Fahr, B.T, Fan, J, Lu, Y, Pham, P, Choong, I.C, VanderPorten, E.C, Bui, M, Purkey, H.E, Evanchik, M.J, Yang, W.Show

Bioorg.Med.Chem.Lett. 18 5648 5652 (2008)

PMID: 18793847 DOI: 10.1016/j.bmcl.2008.08.095

Abstact

A series of 2-amino-pyrazolopyridines was designed and synthesized as Polo-like kinase (Plk) inhibitors based on a low micromolar hit. The SAR was developed to provide compounds exhibiting low nanomolar inhibitory activity of Plk1; the phenotype of treated cells is consistent with Plk1 inhibition. A co-crystal structure of one of these compounds with zPlk1 confirms an ATP-competitive binding mode.

Legend

Protein

Chemical

Disease

Primary Citation of related structures